L. helveticus R0052 and B. longum R0175
APB-C1
Approved other active
Quick answer
L. helveticus R0052 and B. longum R0175 for Attention Deficit Hyperactivity Disorder is a Approved program (other) at ACADIA PHARMACEUTICALS INC with 1 ClinicalTrials.gov record(s).
Program details
- Company
- ACADIA PHARMACEUTICALS INC
- Indication
- Attention Deficit Hyperactivity Disorder
- Phase
- Approved
- Modality
- other
- Status
- active